Health Net (NYSE: HNT) was downgraded by Zacks from a “neutral” rating to an “underperform” rating in a research note issued to investors on Wednesday. They currently have a $23.00 price target on the stock.
A number of other firms have also recently commented on HNT. Analysts at Jefferies Group (NYSE: JEF) reiterated a “hold” rating on shares of Health Net in a research note to investors on Friday, May 4th. Separately, analysts at Goldman Sachs (NYSE: GS) upgraded shares of Health Net from a “neutral” rating to a “buy” rating in a research note to investors on Friday, May 4th. They now have a $35.00 price target on the stock. Finally, analysts at Wells Fargo & Co. (NYSE: WFC) downgraded shares of Health Net from an “outperform” rating to a “market perform” rating in a research note to investors on Thursday, May 3rd.
Health Net opened at 25.81 on Wednesday. Health Net has a 1-year low of $20.51 and a 1-year high of $41.22. The company has a market cap of $2.150 billion and a price-to-earnings ratio of 14.64.
Health Net last released its earnings data on Thursday, May 3rd. The company reported ($0.32) earnings per share for the quarter, missing the analysts’ consensus estimate of $0.60 by $0.92. Health Net’s revenue was down 15.8% compared to the same quarter last year. Analysts expect that Health Net will post $0.77 EPS next quarter.
Health Net, Inc. is a managed care company that delivers managed health care services through health plans and Government-sponsored managed care plans.